| 1 | positive regulation of male gonad development (GO:2000020) | 6.61680548 |
| 2 | negative regulation of metanephros development (GO:0072217) | 5.85513750 |
| 3 | regulation of male gonad development (GO:2000018) | 5.40644038 |
| 4 | chaperone-mediated protein transport (GO:0072321) | 4.99315200 |
| 5 | chromatin remodeling at centromere (GO:0031055) | 4.96823990 |
| 6 | CENP-A containing nucleosome assembly (GO:0034080) | 4.77586631 |
| 7 | cellular response to gonadotropin stimulus (GO:0071371) | 4.72858200 |
| 8 | mesenchymal to epithelial transition (GO:0060231) | 4.44049667 |
| 9 | notochord development (GO:0030903) | 4.33474128 |
| 10 | establishment of integrated proviral latency (GO:0075713) | 4.23713482 |
| 11 | histone exchange (GO:0043486) | 4.09374826 |
| 12 | short-chain fatty acid metabolic process (GO:0046459) | 4.08968121 |
| 13 | IMP biosynthetic process (GO:0006188) | 4.00030550 |
| 14 | metanephric mesenchyme development (GO:0072075) | 3.98108309 |
| 15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.91887934 |
| 16 | regulation of helicase activity (GO:0051095) | 3.91173049 |
| 17 | ubiquinone biosynthetic process (GO:0006744) | 3.85707713 |
| 18 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.73146875 |
| 19 | peptidyl-histidine modification (GO:0018202) | 3.68121889 |
| 20 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.62780900 |
| 21 | mitotic metaphase plate congression (GO:0007080) | 3.61707939 |
| 22 | cardiac right ventricle morphogenesis (GO:0003215) | 3.60825439 |
| 23 | purine nucleobase biosynthetic process (GO:0009113) | 3.60354237 |
| 24 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.56296580 |
| 25 | DNA replication-independent nucleosome organization (GO:0034724) | 3.56296580 |
| 26 | diaphragm development (GO:0060539) | 3.54306284 |
| 27 | anterior/posterior axis specification, embryo (GO:0008595) | 3.53751595 |
| 28 | protein-chromophore linkage (GO:0018298) | 3.51289671 |
| 29 | muscle cell fate commitment (GO:0042693) | 3.50470686 |
| 30 | ubiquinone metabolic process (GO:0006743) | 3.49813532 |
| 31 | skeletal muscle organ development (GO:0060538) | 3.47114598 |
| 32 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.46938008 |
| 33 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.46790494 |
| 34 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.44784455 |
| 35 | glomerulus development (GO:0032835) | 3.44386033 |
| 36 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.43871976 |
| 37 | muscle hypertrophy in response to stress (GO:0003299) | 3.43871976 |
| 38 | cardiac muscle adaptation (GO:0014887) | 3.43871976 |
| 39 | proteasome assembly (GO:0043248) | 3.43136189 |
| 40 | male genitalia development (GO:0030539) | 3.39288552 |
| 41 | base-excision repair, AP site formation (GO:0006285) | 3.39125706 |
| 42 | DNA damage response, detection of DNA damage (GO:0042769) | 3.32364781 |
| 43 | regulation of cardioblast differentiation (GO:0051890) | 3.31175386 |
| 44 | kidney mesenchyme development (GO:0072074) | 3.30655133 |
| 45 | regulation of gene silencing by RNA (GO:0060966) | 3.30111270 |
| 46 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.30111270 |
| 47 | regulation of gene silencing by miRNA (GO:0060964) | 3.30111270 |
| 48 | pseudouridine synthesis (GO:0001522) | 3.26530996 |
| 49 | IMP metabolic process (GO:0046040) | 3.24654100 |
| 50 | negative regulation of telomerase activity (GO:0051974) | 3.23431838 |
| 51 | DNA demethylation (GO:0080111) | 3.20473830 |
| 52 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.17530350 |
| 53 | positive regulation of heart growth (GO:0060421) | 3.14646775 |
| 54 | response to gonadotropin (GO:0034698) | 3.13756881 |
| 55 | regulation of female gonad development (GO:2000194) | 3.11318985 |
| 56 | termination of RNA polymerase III transcription (GO:0006386) | 3.10691130 |
| 57 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.10691130 |
| 58 | nucleobase biosynthetic process (GO:0046112) | 3.10392495 |
| 59 | establishment of viral latency (GO:0019043) | 3.08652431 |
| 60 | quinone biosynthetic process (GO:1901663) | 3.08393258 |
| 61 | regulation of mitochondrial translation (GO:0070129) | 3.07765523 |
| 62 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.05837592 |
| 63 | regulation of meiosis I (GO:0060631) | 3.05190760 |
| 64 | protein targeting to mitochondrion (GO:0006626) | 3.05034951 |
| 65 | rRNA modification (GO:0000154) | 3.03405559 |
| 66 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.02390223 |
| 67 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.02390223 |
| 68 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.02091283 |
| 69 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.96540719 |
| 70 | ATP synthesis coupled proton transport (GO:0015986) | 2.96540719 |
| 71 | embryonic foregut morphogenesis (GO:0048617) | 2.94695932 |
| 72 | fatty acid elongation (GO:0030497) | 2.93968259 |
| 73 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.93941744 |
| 74 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.93662041 |
| 75 | regulation of glomerulus development (GO:0090192) | 2.93237589 |
| 76 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.92275350 |
| 77 | DNA double-strand break processing (GO:0000729) | 2.92047881 |
| 78 | female gonad development (GO:0008585) | 2.90476786 |
| 79 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.89646105 |
| 80 | negative regulation of sister chromatid segregation (GO:0033046) | 2.89646105 |
| 81 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.89646105 |
| 82 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.89646105 |
| 83 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.89646105 |
| 84 | ribosomal small subunit assembly (GO:0000028) | 2.89346438 |
| 85 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.89049455 |
| 86 | regulation of chromatin binding (GO:0035561) | 2.88714203 |
| 87 | metaphase plate congression (GO:0051310) | 2.88491412 |
| 88 | cullin deneddylation (GO:0010388) | 2.85809730 |
| 89 | reproductive system development (GO:0061458) | 2.85535614 |
| 90 | SMAD protein signal transduction (GO:0060395) | 2.85265381 |
| 91 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.83936806 |
| 92 | cellular protein complex localization (GO:0034629) | 2.83882849 |
| 93 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.83112967 |
| 94 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.83112967 |
| 95 | negative regulation of kidney development (GO:0090185) | 2.82678164 |
| 96 | negative regulation of chromosome segregation (GO:0051985) | 2.82365094 |
| 97 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.81825253 |
| 98 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.80391808 |
| 99 | negative regulation of ligase activity (GO:0051352) | 2.80391808 |
| 100 | DNA replication checkpoint (GO:0000076) | 2.79947038 |
VN1R51P 
